Recent Findings Beyond weight reduction, GLP-1RAs have shown positive cardiovascular outcomes in patients with elevated ASCVD risk, heart failure with preserved ejection fraction, obstructive sleep apnea, blood pressure, and dyslipidemia
Unlike older weight-loss drugs, retatrutide brings together three pathways in a single drug
Programs with optional coaching, education, or lifestyle tools can make a big difference in long-term results
Medical Disclaimer This article provides educational information about retatrutide myths and should not replace personalized medical advice
Temperature excursions negate this timeline entirely
This information is not a replacement for prescribed medical treatment for any health condition